A thrombus is an important component of the active and unstable atherosclerotic coronary plaque. A thrombus exhibits unique physical properties and commonly displays profound abnormal vascular ...

Whether the glycoprotein IIb/IIIa inhibitor abciximab is beneficial in patients undergoing elective percutaneous coronary intervention after pretreatment with clopidogrel is unknown. The incidence of ...

The aim of the present study [2] was to assess the relationship between PCI-related time delay and the effectiveness of the intervention in reducing death compared with lytic therapy in acute MI ...

People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...

Among patients with atrial fibrillation and predominantly chronic coronary syndrome undergoing PCI with intravascular imaging ...

Percutaneous coronary intervention (PCI) is a procedure that opens blocked arteries and restores blood flow to the heart. Timely access to hospitals offering PCI services can be a matter of life or ...

Findings from the first-in-human trial of a novel percutaneous ventricular assist device (pVAD) were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & ...

Interventional cardiology made its debut 27 years ago, when Andreas Grüntzig performed the first percutaneous transluminal coronary angioplasty in a human. Since then, rapid expansion of our knowledge ...

Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally invasive procedure to unclog the arteries that feed the heart. While PCI, which includes both ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: ...